Calmare® Scrambler Therapy Clinical Trials and Studies

Apr 30, 2025

Calmare Scrambler Therapy Studies and Research
Calmare Scrambler Therapy Studies and Research

Calmare® Scrambler Therapy is a non-invasive, FDA-cleared treatment designed to alleviate chronic pain by disrupting pain signals through the application of electrical stimulation. Over the past decade, numerous clinical studies and trials have been conducted to evaluate its efficacy, safety, and potential as an alternative to pharmacological pain management. These investigations have explored a variety of chronic pain conditions, including neuropathy, cancer-related pain, and post-surgical pain, providing valuable insights into the therapy’s mechanisms and clinical benefits. Below is a compilation of notable studies and trials that have contributed to the growing body of evidence supporting Calmare® Scrambler Therapy.

Mayo Clinic

“There are now more than 60 scrambler therapy (or Calmare®, 1 trade name) citations listed in PubMed, including successful randomized trials. It is used extensively in the military with good success, especially with neuropathic pain and at experienced pain management centers." Mayo Clinic Proceedings (2021)

Universities

New England Journal of Medicine

"Some of the largest reviews and reports indicate that 10 to 20% of patients have no analgesic response to scrambler therapy, whereas approximately 80 to 90% have a favorable response."

Leading Hospitals and other References

PBS Special on Calmare Scrambler Therapy
© Copyright 2025. Dr. Damon Orlando.
All Rights Reserved. 

Calmare

therapy